As an important part of epigenomics, DNA methylation is involved in processes such as cell and tissue differentiation, development, aging, and environmental adaptation. Changes in DNA methylation patterns are related to multiple diseases, including cancer, mental disorders, diabetes, and cardiovascular disease (CVD). Based on the Illumina chip, CapitalBiotech offers a comprehensive solution for DNA methylation detection and analysis, providing a one-stop service that covers screening and verification.
As an economical and efficient high-throughput screening pfatform for DNA methylation analysis, the illumina 850k methylation array can precisely detect methylation variations at the single-base level. This chip is a powerful tool for researching complex diseases such as tumors, respiratory system disorders, CVD, and mental diseases. It also serves as a high-throughput detection technology platform applicable to Epigenome-Wide Association Studies (EWAS).
CapitalBiotech also provides microarray services including methylation sequencing, methylation analysis, and DNA methylation tests.
Widely Used: Our methylation technology platform is the most cited in scientific literature. It has been utilized to detect methylation in 10,181 samples by the Cancer Genome Atlas (TCGA) program in the United States and 9,246 samples by the International Cancer Genome Consortium (ICGC).
High Cost-Effectiveness: Our platform can analyze over 850,000 methylation sites with single-base resolution, allowing for the precise detection of methylation locations.
High Repeatability: Our DNA methylation analysis technology boasts a technical repeatability correlation (R²) greater than 0.98. Additionally, the correlation (R²) between the 450K intersection probe (850K vs. 450K) is also greater than 0.98.
Experienced: We have years of experience in providing DNA methylation chip services. Our project research areas include tumors, cardiovascular diseases, mental illnesses, immune diseases, drug epigenomes, reproduction and development, stem cells, and traditional Chinese medicine constitution.
Characteristic Analysis: Our data analysis team has extensive experience and has independently developed a illumina 850k methylation array chip analysis process. We offer tailored data analysis plans based on your experimental design. We also correct for cellular components to eliminate the interference of cellular heterogeneity, ensuring more rigorous and reliable results.
As a professional sequencing companies, capital biotech trys our best to provide good products and service for you.
Sign in to leave a comment.